Brief: Unity Biotechnology Q3 Operating Income USD -6.602 Million
04/11/2024 21:30
Nov 04 (Reuters) - Unity Biotechnology Q3 net income USD -6.481 million. * Q3 basic EPS USD -0.38 * Q3 operating expenses USD 6.602 million
Recent news on Unity Biotechnology
See all newsU.S. STOCKS ON THE MOVE-Eve Holding, Magnite, EHang Holdings
U.S. STOCKS ON THE MOVE-Lamb Weston, Robinhood, Eve Holding
Unity Biotechnology slips as co faces Nasdaq delisting, plans dissolution
Brief: Unity Biotechnology Inc - Board Approves Plan Of Dissolution - SEC Filing
Brief: UNITY Biotechnology Estimates $3.7 Million Expenses For Reduction In Force